ADA and Alzheimer disease: However, consistent with the prediction results (Table 2), there was no difference in the anti-oxidant activity of Seq1 and Seq2 in the AD group, and the analogous situation was also observed between Seq3, Seq4, Seq5, Seq6, and Seq7 in the ADA group (Figure 5).